CDSCO approves AstraZeneca's Durvalumab with chemotherapy for gastric/gastroesophageal junction cancer treatment in India.

Study should "offer relief" to patients who need long-term therapy for acid-related disord ...

Appendix cancer cases are increasing among young adults. Know the causes, warning signs, types, diagnosis methods, and modern ...

Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...

The Central Drugs Standard Control Organisation (CDSCO) has granted approval for Durvalumab in combination with FLOT ...

AstraZeneca receives CDSCO approval for Durvalumab, enhancing treatment options for resectable gastric cancer in India.

Nasopharyngeal carcinoma (NPC) has emerged as a defining cancer challenge for Nagaland, with the state recording the highest incidence in India among both men and women, according to Dr KeveduyiTheyo, ...

Proton pump inhibitors are among the most commonly prescribed medications worldwide, but concerns about a possible link to ...

Immunotherapy, targeted treatments, HIPEC, and new delivery options ...

While heartburn medication can be a lifesaver for those suffering from gastric reflux, several studies over the years have ...

Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...

Astellas Pharma has announced that the Scottish Medicines Consortium has accepted zolbetuximab for use on the NHS in Scotland, marking the first national reimbursement recommendation in the UK for a ...